Neuberger Berman Group LLC Cytosorbents Corp Call Options Transaction History
Neuberger Berman Group LLC
- $118 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CTSO
# of Institutions
53Shares Held
17.8MCall Options Held
0Put Options Held
0-
Avenir Corp Washington, DC3.17MShares$2.89 Million0.27% of portfolio
-
Granahan Investment Management, LLC Waltham, MA3.04MShares$2.77 Million0.1% of portfolio
-
Skylands Capital, LLC2.88MShares$2.62 Million0.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.77 Million0.0% of portfolio
-
Sargent Investment Group, LLC1.37MShares$1.24 Million0.29% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $39.7M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...